Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bifidobacterium breve strain:BS2-PB3

ABSTRACT: Bifidobacterium breve strain:BS2-PB3 Genome sequencing

PROVIDER: PRJNA1034991 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Bifidobacterium breve strain:BS2-PS1 | isolate:BS2-PS1

Project description:Bifidobacterium breve strain:BS2-PS1 | isolate:BS2-PS1 Genome sequencing

| PRJNA1128350 | ENA

Bifidobacterium breve strain:BS2-PS2 | isolate:BS2-PS2

Project description:Bifidobacterium breve strain:BS2-PS2 | isolate:BS2-PS2 Genome sequencing

| PRJNA1128354 | ENA

Metabolism of sialic acid by Bifidobacterium breve UCC2003

Project description:Bifidobacteria constitute a specific group of commensal bacteria which inhabit the gastrointestinal tract of humans and other mammals. Bifidobacterium breve UCC2003 has previously been shown to utilise several plant-derived carbohydrates that include cellodextrins, starch and galactan. In the current study, we investigate the ability of this strain to utilise the mucin- and human milk oligosaccharide (HMO)-derived carbohydrate, sialic acid. Using a combination of transcriptomic and functional genomic approaches, we identified a gene cluster dedicated to the uptake and metabolism of sialic acid. Furthermore, we demonstrate that B. breve UCC2003 can cross feed on sialic acid derived from the metabolism of 3’ sialyllactose, a HMO, by Bifidobacterium bifidum PRL2010.

2014-05-29 | GSE56291 | GEO

Cross-feeding by Bifidobacterium breve UCC2003 during Bifidobacterium bifidum PRL2010 growth on a mucin-based medium.

Project description:Bifidobacteria constitute commensal bacteria that commonly inhabit the mammalian gastro intestinal tract. The gut commensal Bifidobacterium breve UCC2003 was previously shown to utilise a variety of plant/diet-derived carbohydrates, including cellodextrin, starch and galactan. In the current study, we investigated the ability of this strain to utilize (parts of) a host-derived source of carbohydrate, namely the mucin glycoprotein. Here, we demonstrate that B. breve UCC2003 exhibits growth properties in a mucin-based medium, but only when in the presence of Bifidobacterium bifidum PRL2010, which is known to metabolize mucin. Based on HPAEC analysis, transcriptome data and insertion mutagenesis, it appears that B. breve UCC2003 sustains this improved survival in co-culture by cross-feeding on a combination of fucose, sialic acid and galactose-containing oligosaccharides.

2014-12-17 | GSE59013 | GEO

Bifidobacterium breve

Project description:Bifidobacterium breve Genome sequencing

| PRJNA1077123 | ENA

Bifidobacterium breve strain:JKL2022

Project description:Bifidobacterium breve strain:JKL2022 Genome sequencing

| PRJNA871061 | ENA

Bifidobacterium breve strain:NRBB11

Project description:Bifidobacterium breve strain:NRBB11 Genome sequencing

| PRJNA384046 | ENA

Bifidobacterium breve strain:CCFM1025

Project description:Bifidobacterium breve strain:CCFM1025 Genome sequencing